M 14 Pill - orange round, 6mm

Pill with imprint M 14 is Orange, Round and has been identified as Methotrexate Sodium 2.5 mg. It is supplied by Mylan Pharmaceuticals Inc.

Methotrexate is used in the treatment of Acute Lymphoblastic Leukemia; Acute Lymphocytic Leukemia; Psoriatic Arthritis; Rheumatoid Arthritis; Breast Cancer and belongs to the drug classes antimetabolites, antipsoriatics, antirheumatics, other immunosuppressants. Not for use in pregnancy. Methotrexate 2.5 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for M 14

Imprint: M 14
Strength: 2.5 mg
Color: Orange
Size: 6.00 mm
Shape: Round
Availability: Prescription only
Drug Class: Antimetabolites, Antipsoriatics, Antirheumatics, Other immunosuppressants
Pregnancy Category: X - Not for use in pregnancy
CSA Schedule: Not a controlled drug
Labeler / Supplier: Mylan Pharmaceuticals Inc.
Inactive Ingredients: silicon dioxide, lactose monohydrate, magnesium stearate, microcrystalline cellulose, corn starch, sodium carbonate monohydrate, sodium lauryl sulfate, sodium starch glycolate type A potato, FD&C Red No. 40
Note: Inactive ingredients may vary.

NDC Code	Labeler / Repackager
00378-0014	Mylan Pharmaceuticals Inc.
51079-0670	UDL Laboratories Inc.

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Drug Status

Availability Prescription only Rx

Pregnancy & Lactation Risk data available

CSA Schedule* Not a controlled drug N/A

Approval History Drug history at FDA

User Reviews & Ratings

6.6 / 10